Raiffeisen Bank International’s Ionis Pharmaceuticals IONS Stock Holding History

Raiffeisen Bank International’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.82M	Sell	35,000 -1,000	-3%	-$75.3K	0.03%	253
2026 Q1	$2.61M	Buy	36,000 +1,000	+3%	+$78.9K	0.04%	244
2025 Q4	$2.76M	Sell	35,000 -15,000	-30%	-$1.13M	0.04%	220
2025 Q3	$3.21M	Sell	50,000 -6,754	-12%	-$330K	0.04%	204
2025 Q2	$2.27M	Buy	56,754 +15,000	+36%	+$491K	0.03%	211
2025 Q1	$1.3M	Buy	41,754 +40,000	+2,281%	+$1.31M	0.02%	244
2024 Q4	$62.3K	Buy	+1,754	New	+$65.6K	﹤0.01%	512

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Raiffeisen Bank International's IONS Position: Q2 2026 in Review

Raiffeisen Bank International reduced its Ionis Pharmaceuticals (IONS) stake by 2.8% in Q2 2026, selling an estimated $75.3K and leaving 35,000 shares worth $2.82M. The position accounts for 0.03% of the portfolio, ranked #253.

Raiffeisen Bank International first reported a position in IONS in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.21M in Q3 2025. 516 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Raiffeisen Bank International held 35,000 shares of Ionis Pharmaceuticals worth $2.82M as of Q2 2026.
Raiffeisen Bank International sold 1,000 Ionis Pharmaceuticals shares in Q2 2026, an estimated $75.3K.
Ionis Pharmaceuticals made up 0.03% of Raiffeisen Bank International's portfolio in Q2 2026, its #253 holding.
Raiffeisen Bank International first reported a position in Ionis Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
Raiffeisen Bank International's Ionis Pharmaceuticals position peaked at $3.21M in Q3 2025.
516 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.